bf/NASDAQ:BCDA_icon.jpeg

NASDAQ:BCDAW

BioCardia, Inc.

  • Stock

USD

Last Close

1.28

06/11 21:00

Market Cap

5.52M

Beta: -

Volume Today

115.31K

Avg: -

PE Ratio

−0.73

PFCF: −0.82

OverviewFinancialsAPI

    Description

    BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also develo...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.15-0.1-0.052022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    Revenue (Estimate*)

    100K200K300K400K2022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    *Estimate based on analyst consensus